Gebruikt door |
als |
Naam |
Versie |
2.16.840.1.113883.2.4.3.11.60.121.10.33 |
Inclusie |
uitvoerende zorgaanbieder (3.4)
|
2021‑07‑01 |
2.16.840.1.113883.2.4.3.11.60.121.10.37 |
 |
zorgverlener (assigned contents) (3.5)
|
2021‑07‑01 |
2.16.840.1.113883.2.4.3.11.60.121.10.32 |
 |
auteur
|
2021‑07‑01 |
2.16.840.1.113883.2.4.3.11.60.26.10.10 |
 |
reactie
|
2021‑07‑01 |
2.16.840.1.113883.2.4.3.11.60.26.10.9 |
 |
overgevoeligheid
|
2021‑07‑01 |
2.16.840.1.113883.2.4.3.11.60.26.10.8 |
 |
overgevoeligheid concern act
|
2021‑07‑01 |
2.16.840.1.113883.2.4.3.11.60.26.10.18 |
 |
Organizer Overgevoeligheid
|
2023‑04‑19 |
2.16.840.1.113883.2.4.3.11.60.26.10.13 |
 |
cio medicatie contraindicatie
|
2023‑04‑19 11:33:28 |
2.16.840.1.113883.2.4.3.11.60.26.10.14 |
 |
cio medicatie contraindicatie concern act
|
2023‑04‑19 |
2.16.840.1.113883.2.4.3.11.60.26.10.7 |
 |
Organizer MedicationContraIndication
|
2020‑08‑27 |
2.16.840.1.113883.2.4.3.11.60.3.10.1 |
Inclusie |
CDA recordTarget SDTC NL
|
2021‑07‑01 |